Kiniksa Pharmaceuticals, Ltd.
KNSANASDAQHealthcare● Active
$48.14
$-0.29(-0.59%)
Market Cap$3.6B
P/E Ratio—
52W High$59.87
52W Low$26.27
Kiniksa Pharmaceuticals, Ltd.（KNSA）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · KNSA · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.68B | $0.42B | $0.27B | $0.22B | $0.04B |
| Cost of Revenue | $0.31B | $0.06B | $0.06B | $0.02B | $0.01B |
| Gross Profit | $0.37B | $0.36B | $0.21B | $0.20B | $0.03B |
| Gross Margin %(computed) | 54.63% | 85.61% | 79.09% | 89.60% | 76.39% |
| Operating Expenses | |||||
| R&D Expenses | $0.10B | $0.11B | $0.08B | $0.07B | $0.10B |
| G&A Expenses | $0.00B | $0.16B | $0.00B | $0.00B | $0.00B |
| Total Operating Expenses | $0.29B | $0.41B | $0.24B | $0.19B | $0.19B |
| Operating Income | $0.08B | ($0.05B) | ($0.03B) | $0.01B | ($0.16B) |
| Operating Margin %(computed) | 11.40% | -10.78% | -9.32% | 4.44% | -406.38% |
| Interest Income | $0.00B | $0.01B | $0.01B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | $0.09B | ($0.04B) | ($0.02B) | $0.01B | ($0.16B) |
| Income Tax Expense | $0.03B | $0.01B | ($0.03B) | ($0.17B) | $0.00B |
| Net Income | $0.06B | ($0.04B) | $0.01B | $0.18B | ($0.16B) |
| Net Margin %(computed) | 8.71% | -10.21% | 5.21% | 83.28% | -409.72% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $0.80 | $-0.60 | $0.20 | $2.64 | $-2.30 |
| Wtd Avg Shares | 0.07B | 0.07B | 0.07B | 0.07B | 0.07B |
| EBITDA | $0.09B | ($0.04B) | ($0.02B) | $0.01B | ($0.15B) |
| EBITDA Margin %(computed) | 13.35% | -10.38% | -8.46% | 5.53% | -400.27% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-08 · USD · B
深入了解Kiniksa Pharmaceuticals, Ltd.
关于Kiniksa Pharmaceuticals, Ltd.（KNSA）损益表
Kiniksa Pharmaceuticals, Ltd.（KNSA）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，KNSA实现营收$0.68B，毛利润$0.37B（毛利率54.63%），净利润$0.06B（净利率8.71%）。
常见问题
KNSA · 4 问Kiniksa Pharmaceuticals, Ltd.（KNSA）2025财年营收为$0.68B，同比up60.1%。
KNSA revenueKNSA salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08